TY - JOUR
T1 - Microglia activation and gene expression alteration of neurotrophins in the hippocampus following early-life exposure to E-cigarette aerosols in a murine model
AU - Zelikoff, Judith T.
AU - Parmalee, Nancy L.
AU - Corbett, Kevin
AU - Gordon, Terry
AU - Klein, Catherine B.
AU - Aschner, Michael
N1 - Funding Information:
National Institutes of Health (R01 ES 07731, R01 ES10563, R03 ES024849, R21 ES025415) to M.A. and NYU NIEHS P30ES000260-50 pilot grant (JTZ).
Publisher Copyright:
© The Author 2017. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Recent epidemiological data indicate that the popularity of electronic cigarettes (e-cigarettes), and consequently nicotine use, is rising in both adolescent and adult populations. As nicotine is a known developmental neurotoxin, these products present a potential threat for those exposed during early life stages. Despite this, few studies have evaluated the toxicity of e-cigarettes on the developing central nervous system. The goal of this study was to assess neurotoxicity resulting from early-life exposure to electronic cigarette aerosols in an in vivo model. Specifically, studies here focused on neuroparameters related to neuroinflammation and neurotrophins. To accomplish this, pregnant and neonatal C57BL/6 mice were exposed to aerosols produced from classic tobacco flavor e-cigarette cartridges (with [13 mg/ml] and without nicotine) during gestation (~3 weeks) and lactation (~3 weeks) via whole-body inhalation. Exposure to e-cigarette aerosols with and without nicotine caused significant reductions in hippocampal gene expression of Ngfr and Bdnf, as well as in serum levels of cytokines IL-1β, IL-2, and IL-6. Exposure to e-cigarette aerosols without nicotine enhanced expression of Iba-1, a specific marker of microglia, in the cornus ammonis 1 region of the hippocampus. Overall, our novel results indicate that exposure to e-cigarette aerosols, with and without nicotine, poses a considerable risk to the developing central nervous system. Consequently, e-cigarettes should be considered a potential public health threat, especially early in life, requiring further research and policy considerations.
AB - Recent epidemiological data indicate that the popularity of electronic cigarettes (e-cigarettes), and consequently nicotine use, is rising in both adolescent and adult populations. As nicotine is a known developmental neurotoxin, these products present a potential threat for those exposed during early life stages. Despite this, few studies have evaluated the toxicity of e-cigarettes on the developing central nervous system. The goal of this study was to assess neurotoxicity resulting from early-life exposure to electronic cigarette aerosols in an in vivo model. Specifically, studies here focused on neuroparameters related to neuroinflammation and neurotrophins. To accomplish this, pregnant and neonatal C57BL/6 mice were exposed to aerosols produced from classic tobacco flavor e-cigarette cartridges (with [13 mg/ml] and without nicotine) during gestation (~3 weeks) and lactation (~3 weeks) via whole-body inhalation. Exposure to e-cigarette aerosols with and without nicotine caused significant reductions in hippocampal gene expression of Ngfr and Bdnf, as well as in serum levels of cytokines IL-1β, IL-2, and IL-6. Exposure to e-cigarette aerosols without nicotine enhanced expression of Iba-1, a specific marker of microglia, in the cornus ammonis 1 region of the hippocampus. Overall, our novel results indicate that exposure to e-cigarette aerosols, with and without nicotine, poses a considerable risk to the developing central nervous system. Consequently, e-cigarettes should be considered a potential public health threat, especially early in life, requiring further research and policy considerations.
KW - Astrocytes
KW - Developmental neurotoxicology
KW - Neurotoxicity
KW - Neurotoxicology
KW - Neurotransmitter
UR - http://www.scopus.com/inward/record.url?scp=85052653797&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052653797&partnerID=8YFLogxK
U2 - 10.1093/TOXSCI/KFX257
DO - 10.1093/TOXSCI/KFX257
M3 - Article
C2 - 29161446
AN - SCOPUS:85052653797
SN - 1096-6080
VL - 162
SP - 276
EP - 286
JO - Toxicological Sciences
JF - Toxicological Sciences
IS - 1
ER -